{
    "organizations": [],
    "uuid": "06c7f3720901d5e7f3c8cec51e32d885ac075577",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-armo-biosciences-announces-positiv/brief-armo-biosciences-announces-positive-outcome-of-first-interim-analysis-in-sequoia-phase-3-pancreatic-cancer-study-idUSFWN1R80IB",
    "ord_in_thread": 0,
    "title": "BRIEF-Armo Biosciences Announces Positive Outcome Of First Interim Analysis In Sequoia Phase 3 Pancreatic Cancer Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Armo Biosciences Inc:\n* ARMO BIOSCIENCES ANNOUNCES POSITIVE OUTCOME OF FIRST INTERIM ANALYSIS IN SEQUOIA PHASE 3 PANCREATIC CANCER STUDY\n* ARMO BIOSCIENCES INC - DMC RECOMMENDED THAT STUDY CONTINUE WITHOUT MODIFICATION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-26T20:21:00.000+03:00",
    "crawled": "2018-03-27T11:38:15.029+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "armo",
        "bioscience",
        "inc",
        "armo",
        "bioscience",
        "announces",
        "positive",
        "outcome",
        "first",
        "interim",
        "analysis",
        "sequoia",
        "phase",
        "pancreatic",
        "cancer",
        "study",
        "armo",
        "bioscience",
        "inc",
        "dmc",
        "recommended",
        "study",
        "continue",
        "without",
        "modification",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}